HAYDEN MICHAEL R has a total of 11 patent applications. Its first patent ever was published in 1991. It filed its patents most often in United States and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are INDEVUS PHARMACEUTICALS INC, ASSIST PUBLIQUE HOPITAUX PARIS APHP and ALEXION PHARMA INTERNAT SARL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | Canada | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Agriculture | |
#5 | Measurement | |
#6 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Animal care | |
#6 | Measuring microorganism processes | |
#7 | Enzymes | |
#8 | Unspecified technologies | |
#9 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Hayden Michael R | 11 |
#2 | Hall Noel | 3 |
#3 | Pimstone Simon N | 2 |
#4 | Ma Yuanhong | 1 |
#5 | Gray-Keller Mark P | 1 |
#6 | Carleton Bruce | 1 |
#7 | Miyazaki Makoto | 1 |
#8 | Kastelein John J P | 1 |
#9 | Henderson Howard E | 1 |
#10 | Brooks-Wilson Angela R | 1 |
Publication | Filing date | Title |
---|---|---|
US2015030581A1 | LPL variant therapeutics | |
US2006235070A1 | Compositions and methods for treating vascular, autoimmune, and inflammatory diseases | |
CA2035177A1 | Lipoprotein lipase mutants |